Orphan designation: posnafusp alfa Treatment of mucopolysaccharidosis type IIIA (Sanfilippo A syndrome), 14/01/2022 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 June 2025 - 14:05

Orphan designation: posnafusp alfa Treatment of mucopolysaccharidosis type IIIA (Sanfilippo A syndrome), 14/01/2022 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2560

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters